Lineage Cell Therapeutics (LCTX) Return on Assets [ROA] (2011 - 2026)
Lineage Cell Therapeutics' Return on Assets [ROA] was -29.76% in Q2 2026, up 10.48 percentage points from -40.24% a year earlier and up 27.88 percentage points from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Lineage Cell Therapeutics came in at -56.13%, down 38.78 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of -38.40 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -17.35% in FY2024 (+1.77 pp), -19.12% in FY2023 (-1.45 pp), -17.67% in FY2022 (+12.96 pp) and -30.63% in FY2021 (-12.91 pp).
- The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q1 2025.
- Compared with a year earlier, Return on Assets [ROA] was higher in four of the last eight quarters, with an average year-over-year change of -17.18 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2023 (a gain of 16.66 percentage points); the worst was Q3 2025 (a drop of 54.72 percentage points).
- Per Business Quant data, LCTX's Return on Assets [ROA] in the three quarters before Q2 2026 was -57.64% (Q1 2026), -62.67% (Q4 2025) and -74.83% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Lineage Cell Therapeutics | 235.20 Mn | 33.61 Mn | - | -29.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.76% |
| Mar 31, 2026 | -57.64% |
| Dec 31, 2025 | -62.67% |
| Sep 30, 2025 | -74.83% |
| Jun 30, 2025 | -40.24% |
| Mar 31, 2025 | -14.37% |
| Dec 31, 2024 | -17.71% |
| Sep 30, 2024 | -20.11% |
| Jun 30, 2024 | -22.91% |
| Mar 31, 2024 | -22.56% |
| Dec 31, 2023 | -20.74% |
| Sep 30, 2023 | -21.23% |
| Jun 30, 2023 | -19.64% |
| Mar 31, 2023 | -19.98% |
| Dec 31, 2022 | -20.68% |
| Sep 30, 2022 | -36.83% |
| Jun 30, 2022 | -36.30% |
| Mar 31, 2022 | -30.66% |
| Dec 31, 2021 | -28.30% |
| Sep 30, 2021 | -9.05% |
API Access
Lineage Cell Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();